Bioinformatic transaction scheme
0 Assignments
0 Petitions
Accused Products
Abstract
Secure network transaction system obtains user-authorized genetic term or bioinformatic profile, and transacts online service according to genetically-based user medical or other risk determined therefrom. Insurance policy, promotional offer, or other service may dynamically address genetically-based condition. Bioinformatic data classifies user per personal mask which filters subset of user genetic sequence. Risk profile may be calculated according to actuarial statistics, genetics and/or heredity using non-discriminatory rules specified for users in temporal or jurisdictional groups. User transactions are modifiable according to bioinformatic data representing genetically-based risk increase or decrease. Data is securely processed, modulated, and stored by network server for remote access and transaction using various portable user devices.
97 Citations
59 Claims
-
1. (canceled)
-
2. (canceled)
-
3. (canceled)
-
4. (canceled)
-
5. (canceled)
-
6. (canceled)
-
7. (canceled)
-
8. (canceled)
-
9. (canceled)
-
10. (canceled)
-
11. (canceled)
-
12. (canceled)
-
13. (canceled)
-
14. (canceled)
-
15. (canceled)
-
16. (canceled)
-
17. (canceled)
-
18. (canceled)
-
19. (canceled)
-
20. (canceled)
-
21. (canceled)
-
22. (canceled)
-
23. (canceled)
-
24. (canceled)
-
25. (canceled)
-
26. (canceled)
-
27. (canceled)
-
28. (canceled)
-
29. (canceled)
-
30. (canceled)
-
31. (canceled)
-
32. (canceled)
-
33. (canceled)
-
34. (canceled)
-
35. (canceled)
-
36. (canceled)
-
37. (canceled)
-
38. (canceled)
-
39. (canceled)
-
40. (canceled)
-
41. Bioinformatic transaction scheme comprising steps:
-
disclosing voluntarily a genetic sequence associated with a personal risk profile; and
transacting commercially using the disclosed sequence. - View Dependent Claims (42, 43, 44, 45, 46, 47)
-
-
48. Bioinformatic transaction scheme comprising:
-
means for disclosing voluntarily a personal genetic sequence associated with a risk profile; and
means for transacting commercially using the disclosed sequence. - View Dependent Claims (49, 50, 51, 52, 53, 54)
-
-
55. Bioinformatic transaction device comprising:
-
processor; and
storage,wherein the processor accesses a genetic sequence in the storage, such that a person associated with such sequence voluntarily discloses such sequence for commercial transaction. - View Dependent Claims (56, 57, 58, 59)
-
Specification